Exploring Headaches in Pediatric Behçet Disease: Prevalence, Clinical Impact, and Management

Andrea Santangelo1,2, Antonio Corsello3, Gilda Gizzi4

  • 1Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, 16100 Genoa, Italy.

PubMed

Insights

Headaches are common in Pediatric Behçet

Area of Science:

  • Pediatric Rheumatology
  • Pediatric Neurology
  • Systemic Inflammatory Diseases

Background:

  • Pediatric Behçet's Disease (PBD) is a multisystemic inflammatory condition.
  • Headaches are a frequent yet under-recognized symptom in PBD.
  • Understanding headache in PBD is crucial for diagnosis and management.

Purpose of the Study:

  • To review the prevalence, burden, and management of headaches in Pediatric Behçet's Disease.
  • To explore the link between systemic inflammation and neurological symptoms in PBD headaches.
  • To highlight the significance of tailored headache management strategies for PBD patients.

Main Methods:

  • Systematic literature review of studies published between 2004 and 2024.
  • Analysis of primary (migraine, tension-type) and secondary headaches in PBD.
  • Examination of pathophysiological mechanisms and clinical significance.

Main Results:

  • Headache is highly prevalent in children with PBD.
  • Both primary and secondary headaches occur, often related to systemic inflammation.
  • PBD-related headaches present unique diagnostic and therapeutic challenges.

Conclusions:

  • Comprehensive evaluation and tailored management are essential for headaches in PBD.
  • Increased awareness of PBD headaches can improve patient outcomes.
  • Further research into PBD headache pathophysiology is warranted.

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
54
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
68
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
107
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
538
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
156
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
257